Skip to main content
. Author manuscript; available in PMC: 2015 Mar 25.
Published in final edited form as: Nature. 2014 Jul 16;513(7519):564–568. doi: 10.1038/nature13577

Figure 3. IL-33 promotes Treg cell stability and function in vivo.

Figure 3

a, C57BL/6 Rag1−/− mice were injected with CD45.1+ naïve T cells alone (RBhi, n = 4) or in combination with WT (n = 4) or St2−/− (n = 6) CD45.1 Treg cells. Mice were sacrificed after 6-8 weeks post transfer and colitis scores are shown. b, Absolute numbers of colon lamina propria (LP) cells from mice in (a). c, C57BL/6 Rag1−/− mice were injected as in (a) and sacrificed at 2 weeks post injection. Representative plots are gated on colonic Treg cell progeny (CD45.1). d, Ratio of RBhi T cell progeny (CD45.1+) to WT or St2−/− Foxp3+ Treg cell progeny (CD45.1) in the colon (n = 5 per group) from mice in (c), (mean ± s.e.m). e, C57BL/6 Rag1−/− mice were injected as in (a) and sacrificed at 8 weeks post injection. Representative plots are gated on colonic Treg cell progeny (CD45.1). f, Ratio of RBhi T cell progeny (CD45.1+) to WT or St2−/− Treg cell progeny (CD45.1) in the colon from mice in (e), (mean ± s.e.m). g, Absolute numbers of RBhi T cell progeny (CD45.1+) in the colon from mice in (e), (mean ± s.e.m). h, Analysis of Foxp3 expression in colonic Foxp3+CD45.1 Treg cells presented as gMFI (mean ± s.e.m).

Results are representative of two independent experiments. *P<0.05 **P<0.01 *** P<0.001 **** P<0.0001 as calculated by 1way-ANOVA with Bonferroni post-test or Students’ t-test.

HHS Vulnerability Disclosure